insights_auto
Why is XTLB up 9.55%?
Dive Deeperchevron_right
XTLB:NASDAQ
X T L Biopharmaceuticals Ltd
$2.41
arrow_upward
+9.55%(+0.21) 1D
$2.28
arrow_downward
-5.46% (-0.13)todayPre-market
Closed: Sep 24, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for XTLB...
Open
$2.22
High
$2.50
Low
$2.22
Mkt. cap
11.15M
Avg. vol.
8.73K
Volume
117.00
52-wk high
$10.28
52-wk low
$2.02
EPS
-$0.34
Beta
1.01
Shares outstanding
4.24M
No. of employees
5
Open
$2.22
High
$2.50
Low
$2.22
Mkt. cap
11.15M
Avg. vol.
8.73K
Volume
117.00
52-wk high
$10.28
52-wk low
$2.02
EPS
-$0.34
Beta
1.01
Shares outstanding
4.24M
No. of employees
5
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 weeks ago
XTL Biopharmaceuticals (XTLB) Advances 4.2% to $2.48 as Clinical-Stage Biotech Draws Fresh Buying Interest - Beta Neutral Pair
About X T L Biopharmaceuticals Ltd
CEO-
Employees5
Founded1993
HeadquartersHerzliya, Tel Aviv District, Israel
SectorBiotechnology
Websitextlbio.com